{
    "Trade/Device Name(s)": [
        "IgG Anti-AtherOx\u2122 Test Kit",
        "IgG Anti-AtherOx Test Kit"
    ],
    "Submitter Information": "Corgenix, Inc.",
    "510(k) Number": "K072032",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022992"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MSV"
    ],
    "Summary Letter Date": "April 4, 2008",
    "Summary Letter Received Date": "March 7, 2008",
    "Submission Date": "March 6, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies to oxidized low-density lipoprotein (oxLDL)/\u03b22-glycoprotein I (\u03b22GPI) complex"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "96-well polystyrene microtiter plate"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunoassay (ELISA)",
        "Indirect ELISA"
    ],
    "Methodologies": [
        "Immunological detection",
        "Binding assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Corgenix IgG Anti-AtherOx ELISA kit for detection of IgG antibodies to oxLDL/\u03b22GPI complexes in autoimmune diseases",
    "Indications for Use Summary": "ELISA for detecting IgG antibodies to oxidized LDL/\u03b22GPI complexes in individuals with systemic lupus erythematosus (SLE) and lupus-like disorders (antiphospholipid syndrome)",
    "fda_folder": "Immunology"
}